Appeals Court Upholds Merck’s Unclean Hands Verdict

Citing a Merck in-house attorney’s dishonesty under oath, the Federal Circuit upheld a 2016 ruling that dismissed a $200 million verdict against Gilead, affirming that Merck unethically obtained the rights to two patents.
Source: Drug Industry Daily